The Business Times

stem cell

Consumer & Healthcare

‘A GPS for stem cells’: TargaZyme’s Singapore CEO wants to cure cancer

The company aims to develop cancer immunotherapies using its cell efficacy multiplier technology.

Yakin Medic’s plans come on the heels of several measures unveiled by the Monetary Authority of Singapore’s review group to revive the local bourse.
Companies & Markets

Malaysian stem cell therapy provider Yakin Medic aims to raise RM100 million in Catalist IPO: report

The company’s proposed listing is currently slated for the fourth quarter of 2025 or early 2026

Cordlife’s report to SGX RegCo noted more than 10 episodes between November 2020 and July 2022 when certain tanks had out-of-range temperature fluctuations.
Consumer & Healthcare

Cordlife probe finds temperature in one tank went as high as 20.4 deg C in 2021

It’s trying to find out why critical incidents involving several storage tanks were not immediately reported 

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More